Cresanto Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve 1. Un-audited Financial Results ....

BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400001 Scrip code: 531207 Subject: Intimation of Board Meeting. Ref: Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/ Madam, In term of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby intimated that the Meeting of Board of Directors of the Company is scheduled to be held on Thursday, 13th August, 2026 at the corporate office of the company to inter alia consider and approve: 1. Un-audited Financial Results of the Company for the first quarter ended 30th June, 2026. 2. Limited Review Report for the quarter ended 30th June, 2026. 3. Change in corporate office of the Company and place for maintaining and keeping the books of Accounts of the Company. 4. Any other business with the permission of chair. Further, in terms of the Prohibition of Insider Trading Code adopted by the Company the Window Closure for Trading by Designated Persons of the Company shall remain close from Wednesday, 1st July, 2026 till 48 hours after the declaration of Unaudited Financial Results of the Company on Thursday, 13th August, 2026 for the quarter ended 30th June, 2026. Any other business with the permission of chair. Kindly take the record of the same. Thanking you, For Cresanto Global Limited (Formerly known as Raymed Labs Limited) (Prashant Nathmal Bajaj) Managing Director DIN: 06634046 Date: 07th August, 2026 Place: Mumbai Corporate Office: 201, 2nd Floor, A wing, Corporate Avenue, Sonawala Lane, Goregaon East, Mumbai-400063